Publications by authors named "Karen Matta"

Claim this Profile
[
[Blood protein-induced microglial activation in neurodegenerative diseases].
Coraly Simoës Da Gama, Karen Matta, Guillaume Dorothée, Mélanie Morin-Brureau

Med Sci (Paris)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory T cells decrease C3-positive reactive astrocytes in Alzheimer-like pathology.
Grégoire Stym-Popper, Karen Matta, Thomas Chaigneau, Roshan Rupra, Alexandros Demetriou

J Neuroinflammation· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blocking interleukin-23 ameliorates neuromuscular and thymic defects in myasthenia gravis.
José A Villegas, Jérôme Van Wassenhove, Judith Merrheim, Karen Matta, Samy Hamadache

J Neuroinflammation· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perifosine treatment in chronic lymphocytic leukemia: results of a phase II clinical trial and in vitro studies.
Daphne R Friedman, Mark C Lanasa, Patricia H Davis, Sallie D Allgood, Karen M Matta

Leuk Lymphoma· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of cenersen, an antisense inhibitor of p53, in combination with fludarabine, cyclophosphamide and rituximab for high-risk chronic lymphocytic leukemia.
Mark C Lanasa, Patricia H Davis, Michael Datto, Zhiguo Li, Jon P Gockerman, Karen M B Matta

Leuk Lymphoma· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target.
Dale J Christensen, Youwei Chen, Jessica Oddo, Karen M Matta, Jessica Neil

Blood· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The BMP antagonist Noggin promotes cranial and spinal neurulation by distinct mechanisms.
Rolf W Stottmann, Mark Berrong, Karen Matta, Murim Choi, John Klingensmith

Dev Biol· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis